LEP-AD: language embedding of proteins and attention to drugs predicts drug-target interactions

INTRODUCTION: Predicting drug-target interactions remains a significant challenge in drug development and lead optimization. Recent advances have leveraged machine learning algorithms to model drug-target interactions from molecular and sequence data. MATERIALS AND METHODS: In this work, we use Evolutionary Scale Modeling (ESM-3) to construct a transformer-based protein language representation for drug-target interaction prediction. We introduce LEP-AD (Language Embedding of Proteins and Attention to Drugs), a modular architecture that combines pretrained protein language models with graph-based molecular encoders to predict binding affinity values. RESULTS: We systematically benchmark LEP-AD alongside a range of established deep learning methods across multiple datasets-Davis, KIBA, DTC, Metz, ToxCast, and STITCH. To assess predictive validity, we compare model-derived rankings of drug-target interactions with experimental results reported in the literature. In addition, we perform new experimental assays to evaluate the binding of three ATP-competitive Src kinase inhibitors-Dasatinib, UM-164, and Saracatinib-where experimentally measured IC₅₀ and pKᵢ values are consistent with the predicted rankings. CONCLUSION: In summary, our benchmark highlights the strengths and limitations of current drug-target interaction models across diverse datasets and evaluation settings. The results emphasize the impact of pretrained protein and molecular representations on predictive performance and illustrate the persistent challenges of generalization, while the modular LEP-AD framework provides a flexible reference point for comparative evaluation. SCIENTIFIC CONTRIBUTION: This study presents LEP-AD, a modular deep learning framework for drug-target interaction prediction that integrates pretrained protein language representations with graph-based molecular encoders. Beyond introducing the architecture, we provide a systematic benchmark under similarity-aware evaluation settings and experimental validation, highlighting the impact of pretrained protein embeddings on predictive behavior across diverse datasets.

Authors

Institutions

Publication Details

Journal
Journal of Cheminformatics
Published
2026-04-27
DOI
https://doi.org/10.1186/s13321-026-01167-9
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LEP-AD: language embedding of proteins and attention to drugs predicts drug-target interactions

Anuj Daga, Robert Lehmann, Raik Grünberg, Stefan T. Arold et al.
Journal of Cheminformatics
Computational Drug Discovery Methods
article

LEP-AD: language embedding of proteins and attention to drugs predicts drug-target interactions

Anuj Daga, Robert Lehmann, Raik Grünberg, Stefan T. Arold, Ahmed Abogosh, Reem Alsulami, Narsis A. Kiani, Jesper Tegner, Sumeer A. Khan, Robert Hoehndorf, David Gomez Cabrero
article en

Abstract

INTRODUCTION: Predicting drug-target interactions remains a significant challenge in drug development and lead optimization. Recent advances have leveraged machine learning algorithms to model drug-target interactions from molecular and sequence data. MATERIALS AND METHODS: In this work, we use Evolutionary Scale Modeling (ESM-3) to construct a transformer-based protein language representation for drug-target interaction prediction. We introduce LEP-AD (Language Embedding of Proteins and Attention to Drugs), a modular architecture that combines pretrained protein language models with graph-based molecular encoders to predict binding affinity values. RESULTS: We systematically benchmark LEP-AD alongside a range of established deep learning methods across multiple datasets-Davis, KIBA, DTC, Metz, ToxCast, and STITCH. To assess predictive validity, we compare model-derived rankings of drug-target interactions with experimental results reported in the literature. In addition, we perform new experimental assays to evaluate the binding of three ATP-competitive Src kinase inhibitors-Dasatinib, UM-164, and Saracatinib-where experimentally measured IC₅₀ and pKᵢ values are consistent with the predicted rankings. CONCLUSION: In summary, our benchmark highlights the strengths and limitations of current drug-target interaction models across diverse datasets and evaluation settings. The results emphasize the impact of pretrained protein and molecular representations on predictive performance and illustrate the persistent challenges of generalization, while the modular LEP-AD framework provides a flexible reference point for comparative evaluation. SCIENTIFIC CONTRIBUTION: This study presents LEP-AD, a modular deep learning framework for drug-target interaction prediction that integrates pretrained protein language representations with graph-based molecular encoders. Beyond introducing the architecture, we provide a systematic benchmark under similarity-aware evaluation settings and experimental validation, highlighting the impact of pretrained protein embeddings on predictive behavior across diverse datasets.

Journal of Cheminformatics
Karolinska University Hospital (SE), Universidad Pública de Navarra (UPNA) (ES), Science for Life Laboratory (SE), Karolinska Institutet (SE), Navarrabiomed (ES), King Abdullah University of Science and Technology (SA)
Karolinska Institutet
Openalex Percentile: Top 9%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.